medicine-news-1/ntu-and-sembcorp-to-jointly-explore-novel-waste-water-treatment-technology-49934-1/;msg18067;topicseen

Breaking Biology Technology:YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 2 YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 3 YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 4 YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES 5 Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years 2 Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years 3 Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 2 Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner 3

[0] YM BIOSCIENCES AND THE NATIONAL RESEARCH COUNCIL OF CANADA BIOTECHNOLOGY RESEARCH INSTITUTE (NRC-BRI) PRODUCE NEW BREAST CANCER DRUG CANDIDATES [0] Hertz Annual Appeal for Adult Congenital Heart Disease Center At UCLA Passes $2-Million Mark in Funds Raised Over Ten Years [0] Life Line Screening Joins the Vascular Disease Foundation as Corporate Partner [0] Quest Diagnostics Declares Quarterly Cash Dividend

Breaking Medicine Technology:Circassia Raises GBP15 Million ($25 Million) in Oversubscribed Investment Round 2 Boston Scientific Announces Pricing of $2 Billion of Senior Notes 2 Boston Scientific Announces Pricing of $2 Billion of Senior Notes 3 Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 2 Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 3 Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 4 Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 5 Bavarian Nordic A S Half Year Interim Report 2009 13729 1 Bavarian Nordic A S Half Year Interim Report 2009 13729 2 Bavarian Nordic A S Half Year Interim Report 2009 13729 3 Bavarian Nordic A S Half Year Interim Report 2009 13729 4 Bavarian Nordic A S Half Year Interim Report 2009 13729 5 Bavarian Nordic A S Half Year Interim Report 2009 13729 6 Bavarian Nordic A S Half Year Interim Report 2009 13729 7 Promising Cancer Research Treatment Breakthrough Seeks Funding for Corroboration of Results 55591 1 Promising Cancer Research Treatment Breakthrough Seeks Funding for Corroboration of Results 55591 2 ALOKA Announces New ProSound Alpha Series Ultrasound System 55587 1 ALOKA Announces New ProSound Alpha Series Ultrasound System 55587 2 ALOKA Announces New ProSound Alpha Series Ultrasound System 55587 3

[0] Circassia Raises GBP15 Million ($25 Million) in Oversubscribed Investment Round [0] Boston Scientific Announces Pricing of $2 Billion of Senior Notes [0] Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy